- conflicts or gaps
- [{"name_collision": {"value": "Unrelated Nashville web development firm also named General Proximity (founded 2012) was acquired by Atiba on 2020-01-11; operates at generalproximity.com and is not affiliated with the YC W20 biotech at generalproximity.bio", "source_urls": ["https://www.cbinsights.com/company/general-proximity", "https://tracxn.com/d/companies/generalproximity/__LVlkNBsk4A28F11rJPTi-xN_a3yNxOAhpqb3vg9ep1c", "https://www.ycombinator.com/companies/general-proximity"]}, "company_slug_discrepancy": {"value": "Internal/database slug general_proximity (underscore) vs YC public slug general-proximity (hyphen)", "source_urls": ["https://www.ycombinator.com/companies/general-proximity", "https://yc-oss.github.io/api/batches/winter-2020/general-proximity.json"]}, "founded_year_discrepancy": {"value": "Company and YC sources list 2019; Tracxn lists 2023", "source_urls": ["https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html", "https://tracxn.com/d/companies/generalproximity/__nf1c0yEhvwCpiw9N8WP_OczMEJiIBH088t9HM5orI9M"]}, "employee_count_discrepancy": {"value": "YC reports 15; Tracxn reports 22 as of Apr 2026", "source_urls": ["https://www.ycombinator.com/companies/general-proximity", "https://tracxn.com/d/companies/generalproximity/__nf1c0yEhvwCpiw9N8WP_OczMEJiIBH088t9HM5orI9M"]}, "total_funding_discrepancy": {"value": "Company reports over USD 20M total as of May 2026; Tracxn and Caplight report USD 16M across 2 rounds with May 2026 amount redacted", "source_urls": ["https://www.generalproximity.bio/newsposts/freemind-investments-and-daewoong-pharmaceutical-co-invest-in-general-proximity", "https://tracxn.com/d/companies/generalproximity/__nf1c0yEhvwCpiw9N8WP_OczMEJiIBH088t9HM5orI9M", "https://www.caplight.com/company/generalproximity"]}, "seed_round_framing": {"value": "Dec 2024 Axios reports $8M seed; Jan 2025 de-stealth press release states $16M total seed with $8M portion led by Felicis — same round, different framing", "source_urls": ["https://www.generalproximity.bio/newsposts/exclusive-gp-gets-8m-for-drug-discovery", "https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html"]}, "may_2026_round_amount_gap": {"value": "FreeMind Investments / Daewoong Pharmaceutical May 2026 investment amount not disclosed in primary press release", "source_urls": ["https://www.generalproximity.bio/newsposts/freemind-investments-and-daewoong-pharmaceutical-co-invest-in-general-proximity"]}, "founder_attribution_gap": {"value": "YC lists only Armand Cognetta as founder; Jan 2025 press release references broader founding team of scientists without naming co-founders", "source_urls": ["https://www.ycombinator.com/companies/general-proximity", "https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html"]}, "pre_seed_amount_gap": {"value": "Pre-seed round led by Y Combinator and Jim Dahl (Rock Creek) referenced but amount not disclosed", "source_urls": ["https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html"]}, "valuation_gap": {"value": "No post-money valuation publicly disclosed for any funding round", "source_urls": ["https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html", "https://www.caplight.com/company/generalproximity"]}, "team_metrics_discrepancy": {"value": "Company website cites 40+ FDA-approved medicines; Jan 2025 press release cites 36 FDA-approved medicines for the team", "source_urls": ["https://www.generalproximity.bio/", "https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html"]}, "yc_profile_gaps": {"value": "YC OSS API shows empty long_description; YC news headline references $8M raise while later press states $16M total seed", "source_urls": ["https://yc-oss.github.io/api/batches/winter-2020/general-proximity.json", "https://www.ycombinator.com/companies/general-proximity"]}}]
- source urls
- ["https://tracxn.com/d/companies/generalproximity/__LVlkNBsk4A28F11rJPTi-xN_a3yNxOAhpqb3vg9ep1c", "https://tracxn.com/d/companies/generalproximity/__nf1c0yEhvwCpiw9N8WP_OczMEJiIBH088t9HM5orI9M", "https://www.caplight.com/company/generalproximity", "https://www.cbinsights.com/company/general-proximity", "https://www.finsmes.com/2025/01/general-proximity-raises-16m-in-funding.html", "https://www.generalproximity.bio/", "https://www.generalproximity.bio/newsposts/exclusive-gp-gets-8m-for-drug-discovery", "https://www.generalproximity.bio/newsposts/freemind-investments-and-daewoong-pharmaceutical-co-invest-in-general-proximity", "https://www.generalproximity.bio/team/armand-b-cognetta-iii", "https://www.prnewswire.com/news-releases/general-proximity-announces-multi-target-collaboration-with-daiichi-sankyo-to-discover-and-advance-novel-oncology-therapeutics-using-omnitac-platform-302612832.html", "https://www.prnewswire.com/news-releases/general-proximity-de-stealths-with-16m-to-pioneer-next-gen-induced-proximity-medicines-for-undruggable-targets-302341947.html", "https://www.ycombinator.com/companies/general-proximity", "https://yc-oss.github.io/api/batches/winter-2020/general-proximity.json"]